Learning Objectives
5 objectives- Understand the fundamental principles and history of pharmacotherapy within healthcare.
- Explain pharmacokinetics and pharmacodynamics and their roles in drug action.
- Identify major drug classes, their mechanisms of action, and clinical applications.
- Analyze the importance of therapeutic drug monitoring and manage adverse drug reactions.
- Evaluate pharmacotherapy considerations in special populations and emerging trends.
Content Outline
PreviewUnit 1343: Comprehensive Pharmacotherapy
1. Introduction to Pharmacotherapy
- Overview of pharmacotherapy and its significance in healthcare
- History of pharmacology
- Early drug use and discovery
- Milestones in drug development
- Drug development process
- Preclinical research
- Clinical trials (Phases I-IV)
- Regulatory approval
- Role of pharmacotherapy in modern healthcare systems
2. Pharmacokinetics and Pharmacodynamics
2.1 Pharmacokinetics
- Absorption
- Routes of administration
- Factors affecting absorption
- Distribution
- Protein binding
- Volume of distribution
- Metabolism
- Phase I and Phase II reactions
- Role of liver enzymes (e.g., CYP450)
- Excretion
- Renal and hepatic pathways
- Half-life and clearance
2.2 Pharmacodynamics
- Drug-receptor interactions
- Types of receptors
- Agonists, antagonists, partial agonists
- Dose-response relationships
- Therapeutic index and drug potency
- Mechanisms of drug action
3. Drug Classes and Mechanisms of Action
- Overview of major drug classes
- Antibiotics
- Analgesics and anti-inflammatory drugs
- Cardiovascular drugs
- Central nervous system agents
- Endocrine drugs
- Chemotherapeutic agents
- Mechanisms of action for each class
- Representative drugs and clinical uses
4. Therapeutic Drug Monitoring (TDM)
- Purpose and importance of TDM
- Drugs commonly monitored (e.g., digoxin, lithium, aminoglycosides)
- Methods of measuring drug levels
- Interpretation of results
- Adjusting doses based on TDM
5. Adverse Drug Reactions (ADRs) and Drug Interactions
- Types of ADRs
- Type A (dose-dependent)
- Type B (idiosyncratic/allergic)
- Common adverse effects and toxicities
- Drug-drug interactions
- Pharmacokinetic interactions
- Pharmacodynamic interactions
- Prevention and management of ADRs and interactions
6. Pharmacotherapy in Special Populations
- Pediatric considerations
- Differences in pharmacokinetics and pharmacodynamics
- Dosage adjustments
- Geriatric considerations
- Polypharmacy
- Altered drug metabolism
- Pregnancy and breastfeeding
- Teratogenic risks
- Drug safety categories
7. Pharmacoeconomics and Drug Policy
- Cost-effectiveness analysis
- Budget impact and resource allocation
- Healthcare policies affecting drug access
- Impact of drug pricing on patient outcomes
- Strategies to improve affordability and access
8. Emerging Trends in Pharmacotherapy
- Personalized medicine
- Pharmacogenomics
- Biomarker-guided therapy
- Novel drug delivery systems
- Nanotechnology
- Controlled release formulations
- Advances in biotechnology and drug design
- Future directions in pharmacotherapy
Unlock the full outline
Get the complete content outline, learning outcomes and assessment methods for Pharmacotherapy.
KSh 20 one-off, or included with a plan
Learning Outcomes
Unlock the outline above to see learning outcomes.
Assessment Methods
Unlock the outline above to see assessment methods.